top of page

H7 Accelerator
 
The 2024 Cohort Application is Open Now!

ABOUT H7 ACCELERATOR

Powered by H7 BioCapital, the H7 Accelerator offers a 12-week, equity-free program tailored for healthcare companies at the Pre-Seed to Series A stages. The program includes two specialized tracks: Life Science and Medtech, providing a unique opportunity to immerse in Silicon Valley and achieve strategic business objectives.

 

The program focuses on critical areas such as fundraising and partnership opportunities. The Life Science track emphasizes pre-clinical and clinical development plans and licensing-out opportunities, while the Medtech track concentrates on commercializing or expanding in the U.S. market.

โ€‹

Cohort companies receive one-on-one guidance from over 100 world-leading advisors and have the chance to pitch their innovations during Demo Day and other events to a diverse audience of potential investors, industry leaders, and key stakeholders, enhancing their visibility and growth prospects.

100+
Mentors

One to One
Meetings

80+
VCs

Partnering with H7 Accelerator

12+
Workshops

Customised to
Cohort

12
Week

Personalized
Program

Free
Consultation

Tax, Legal, FDA, Regulations, AWS credits

Funding
Opportunity

Private Investor
Meeting and Events

License Out
& Partnership

Know
more

Meet our current network

Once you are selected to be a part of an accelerator cohort, you will become a permanent member of the H7 community. This will provide you with the opportunity to grow your business and expand your network by connecting with a group of skilled founders, investors, mentors, and industry leaders. 

Benefits of Networking Opportunities

Software Development

Clinical Trail

Science

Team Recruitment

Hospital Management

Business Development

CRO

Marketing / Sales

Clinician

FDA Regulations

Manufacturing

Legal/Patent

dd.png

Accelerator Advisors Network

mentors_edited_edited.png
6.png

Industrial Focus

We are on the lookout for companies that possess cutting-edge healthcare technologies and demonstrate promising commercial viability.

Life Science Track

Stage: Angel to Series A

We innovate within the biotech/biopharma sectors. Our focus areas include drug discovery, personalized medicine, synthetic biology, advanced drug delivery systems, and more. Join us in advancing these cutting-edge fields to revolutionize drug development and transform healthcare.

Medtech Track

Stage: Angel to Series A

Driving innovation in medical technology to enhance patient care and healthcare delivery. Our initiatives span across digital medicine, AI integration, cutting-edge medical devices and digital health platforms aimed at enhancing clinical outcomes and optimizing healthcare processes.

Cohort Timeline

JUNE 20, 2024

Applications Open

SEPTEMBER – DECEMBER 2024

Accelerator Program Launch

JANUARY #, 2025
Demo Day Event

2023

2024

2025

AUGUST 15, 2024

Applications Due

Previous Cohort Interviews

bottom of page